Close
ACHEMA MIDDLE EAST 2026

Xtandi Clones By Sun Pharma – Astellas-Pfizer Settle Case

As per findings pertaining to court filings, Astellas Pharma Inc. and Pfizer Inc. have gone on to reach a settlement in their lawsuit against...

EUGC Sets Last Pin On Pharma Reverse Payment Patent Deals

On October 18, 2023, the General Court of the European Union issued a judgement wherein it went on to reject the appeal made by...

Drug Delivery Via Drones – Get Ready For Exciting Times Ahead

The healthcare industry is experiencing prominent changes because of the rapid advancement of tech. Artificial intelligence- AI is already playing a pivotal role in...

APAC Pandemic Readiness – A Workforce Training Efforts Goal

The Ministry of Health and Welfare in South Korea has gone on to announce a collaborative effort with the Asian Development Bank to carry...

New MHRA Regulation Revamps Lowest-Risk UK Clinical Trials

The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to...

Alternative Tools For Facility Assessments Provided By FDA

The US FDA has gone on to release a draft guidance that outlines its approach to utilising alternative methods so as to evaluate drug...

EU Pharma Reforms Need Revisions – Swedish Stakeholders

The Swedish government this summer has gone on to provide an opportunity for more than 120 stakeholders so as to share their viewpoints on...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...